04 역사상 가장 많이 팔린 약, 아스피린

Summary

• Aspirin’s remarkable success: The video presents aspirin as one of history’s best-selling medicines. It says production reaches tens of thousands of tons annually, with particularly high use in the United States. Since its commercial launch in 1899, aspirin has remained a major product despite the arrival of newer drugs.

• Origins in willow: The account traces aspirin’s roots to willow leaves and bark. It refers to the ancient Greek physician Dioscorides, who recorded using willow preparations to relieve pain. Salicylic acid was later developed from willow-derived material, but it could cause significant stomach irritation.

• Development and launch: Bayer researcher Felix Hoffmann is credited with working on a modified form of salicylic acid—acetylsalicylic acid—intended to reduce the earlier compound’s drawbacks while retaining its pain-relieving and anti-inflammatory effects. The video says the new compound was initially overlooked in the laboratory and reached the market in 1899 under the name Aspirin.

The subtitles contain some unclear or possibly erroneous dates and chemical wording, so the exact details of the development timeline are uncertain.

• Patents and the American market: Aspirin could not be patented in Germany because a French chemist had previously made acetylsalicylic acid. Bayer did secure U.S. patent protection and expanded into the American market. During World War I, the U.S. government took control of German-owned assets, and the rights associated with Bayer’s American business were sold to Sterling Products. The video describes Bayer regaining the U.S. rights in 1994.

• Aspirin as a symbol of its era: The narrator connects aspirin’s popularity in the United States after World War I to widespread social stress and the demand for relief from headaches and pain. The video describes the period as an “Aspirin era” and suggests that the label could also suit the present day.

• Why aspirin seems unusual to drug researchers: The author’s discussion notes that aspirin is a small molecule and has a chemical group that can break down in the body—features that might seem ill-suited to a medicine designed using modern drug-development principles. The video says later research in the 1970s helped explain how aspirin works, but the narrator skips the technical details.

• Antiplatelet effects and cautions: Beyond relieving pain and reducing inflammation, aspirin can inhibit blood clotting. The video discusses this effect in connection with preventing heart attacks and strokes, and mentions possible uses for people at risk of certain clots. It also notes research hypotheses about dementia and several cancers, while stressing that these are not established grounds for widespread preventive use.

The narrator recounts having taken aspirin for its antiplatelet effect but stopping after considering the danger of serious bleeding. The discussion is not a recommendation to start or stop aspirin; medical use should be decided with a qualified clinician.

Speakers and Sources Featured

• Presenter/narrator: The only speaker heard in the subtitles; explains the history and summarizes the author’s arguments.
• Kentaro Sato: The author whose discussion of aspirin the narrator says the video is covering.
• Bayer’s website: Cited by the narrator as a source for aspirin-production figures.
• Historical figures mentioned: Dioscorides, Felix Hoffmann, Franz Kafka, and an unnamed French chemist.
• Organizations mentioned: Bayer, Bayer American, Sterling Products, and the U.S. government.